NASDAQ:ZLAB
Zai Lab Ltd Stock News
$15.91
+0.170 (+1.08%)
At Close: Apr 26, 2024
Zai Lab's Nuzyra Approved In China For Bacterial Infections
08:04am, Thursday, 16'th Dec 2021
The China National Medical Products Administration (NMPA) has approved Zai Lab Limited's (NASDAQ: ZLAB) Nuzyra (omadacycline), a novel antibiotic with both oral and intravenous (IV) formulations. T
Zai Lab Stock (ZLAB): Why The Price Increased Today
07:31am, Thursday, 16'th Dec 2021
The stock price of Zai Lab Ltd (NASDAQ: ZLAB) increased by over 3% pre-market today. This is why it happened.
Why Shares of BeiGene and Zai Lab Are Tanking Today
08:33pm, Wednesday, 15'th Dec 2021 The Motley Fool
The threat of a forced delisting is weighing heavily on these two Chinese biotech stocks.
Why Shares of BeiGene and Zai Lab Are Tanking Today
08:33pm, Wednesday, 15'th Dec 2021 The Motley Fool
The threat of a forced delisting is weighing heavily on these two Chinese biotech stocks.
Why Shares of BeiGene and Zai Lab Are Tanking Today
03:33pm, Wednesday, 15'th Dec 2021
The threat of a forced delisting is weighing heavily on these two Chinese biotech stocks.
Here are the 10 U.S.-listed Chinese stocks with the greatest American ownership — and Alibaba's not one of them
07:34pm, Monday, 13'th Dec 2021
The U.S.-listed Chinese stocks with the most American ownership don't include many of the big names familiar to Wall Street, according to Morgan Stanley.
Zai Labs (ZLAB) Buy Rating Reaffirmed at SVB Leerink
09:06am, Monday, 13'th Dec 2021 Transcript Daily
SVB Leerink reiterated their buy rating on shares of Zai Lab (NASDAQ:ZLAB) in a report released on Sunday morning, Analyst Price Targets reports. ZLAB has been the topic of several other reports. Sanford C. Bernstein started coverage on shares of Zai Lab in a research note on Tuesday, October 12th. They issued a market perform []
Analysts Expect Zai Lab Limited (NASDAQ:ZLAB) Will Announce Quarterly Sales of $55.21 Million
09:30pm, Saturday, 11'th Dec 2021 Transcript Daily
Analysts expect Zai Lab Limited (NASDAQ:ZLAB) to post sales of $55.21 million for the current fiscal quarter, according to Zacks Investment Research. Three analysts have issued estimates for Zai Labs earnings. The lowest sales estimate is $46.50 million and the highest is $62.80 million. The firm is scheduled to announce its next quarterly earnings results []
Insider Buying: Zai Lab Limited (NASDAQ:ZLAB) Director Buys 4,000 Shares of Stock
10:40am, Friday, 10'th Dec 2021 Dakota Financial News
Zai Lab Limited (NASDAQ:ZLAB) Director Peter Wirth acquired 4,000 shares of the firms stock in a transaction that occurred on Wednesday, December 8th. The shares were bought at an average price of $71.36 per share, with a total value of $285,440.00. The transaction was disclosed in a document filed with the SEC, which is available []
Zai Lab Limited (NASDAQ:ZLAB) Director Acquires $285,440.00 in Stock
04:20am, Thursday, 09'th Dec 2021 Transcript Daily
Zai Lab Limited (NASDAQ:ZLAB) Director Peter Wirth acquired 4,000 shares of the companys stock in a transaction that occurred on Wednesday, December 8th. The stock was acquired at an average cost of $71.36 per share, for a total transaction of $285,440.00. The transaction was disclosed in a legal filing with the SEC, which is accessible []
Zacks: Brokerages Anticipate Zai Lab Limited (NASDAQ:ZLAB) Will Post Earnings of -$1.65 Per Share
11:38am, Tuesday, 07'th Dec 2021 Transcript Daily
Wall Street analysts expect Zai Lab Limited (NASDAQ:ZLAB) to announce earnings per share (EPS) of ($1.65) for the current fiscal quarter, Zacks Investment Research reports. Three analysts have issued estimates for Zai Labs earnings. The lowest EPS estimate is ($1.82) and the highest is ($1.45). The firm is expected to issue its next quarterly earnings []
Zai Lab Limited (NASDAQ:ZLAB) Expected to Announce Quarterly Sales of $55.21 Million
06:56am, Monday, 06'th Dec 2021 ETF Daily News
Wall Street brokerages expect that Zai Lab Limited (NASDAQ:ZLAB) will report $55.21 million in sales for the current quarter, Zacks Investment Research reports. Three analysts have provided estimates for Zai Labs earnings. The lowest sales estimate is $46.50 million and the highest is $62.80 million. The business is expected to announce its next earnings report [] The post Zai Lab Limited (NASDAQ:ZLAB) Expected to Announce Quarterly Sales of $55.21 Million appeared first on ETF Daily News .
Zai Lab (NASDAQ:ZLAB) PT Raised to $231.00 at Citigroup
12:00pm, Saturday, 04'th Dec 2021 Dakota Financial News
Zai Lab (NASDAQ:ZLAB) had its price target boosted by Citigroup from $217.00 to $231.00 in a research report sent to investors on Friday morning, The Fly reports. The firm currently has a buy rating on the stock. A number of other brokerages also recently weighed in on ZLAB. SVB Leerink cut their price target on []
Baillie Gifford & Co. Has $515.91 Million Stock Position in Zai Lab Limited (NASDAQ:ZLAB)
03:52pm, Friday, 03'rd Dec 2021 Dakota Financial News
Baillie Gifford & Co. lifted its holdings in shares of Zai Lab Limited (NASDAQ:ZLAB) by 21.1% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 4,895,281 shares of the companys stock after purchasing an additional 853,991 shares during the quarter. Baillie []
Zai Lab Announces Inclusion of ZEJULA® (Niraparib) in China’s National Reimbursement Drug List for First-Line Ovarian Cancer
12:30pm, Friday, 03'rd Dec 2021 GlobeNewswire Inc.
SHANGHAI, SAN FRANCISCO, and CAMBRIDGE, Mass., Dec. 03, 2021 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a patient-focused, innovative, commercial-stage, global biopharmaceutical